Quality Risk Management

Similar documents
ICH Quality Implementation Working Group POINTS TO CONSIDER

Quality Implementation Working Group on Q8, Q9 and Q10 Questions & Answers

Pharmaceutical Quality System (PQS)

Inspection. Implementation of ICH Q8, Q9, Q10

Control Strategy. Implementation of ICH Q8, Q9, Q10

Textvergleich. Verglichene Dokumente MEDIA3917.pdf. ICH_Q10_Step4.pdf

Regulatory Assessment

Q10 PHARMACEUTICAL QUALITY SYSTEM

Challenges in Implementing Knowledge Management within ICH Q10

Guidance for Industry

Notice. Health Canada is pleased to announce the adoption of the ICH guidance Q8, Q9 and Q10 Questions & Answers (R4).

WHO guidelines on quality risk management

QbD approach and Regulatory Challenges in Europe

Quality Systems. Indian Pharmaceutical Alliance. Advanced GMP Workshops 2017

Europe s new approach to assurance of API quality and its implications for manufacturers and producing countries

ICH Q11 Development & manufacture of drug substances

Enabling Improvement through the Product Lifecycle: Change Management within a PQS

ROLE OF ICH GUIDELINES IN PHARMACEUTICAL QUALITY RISK MANGAMENT- REVIEW

Regulatory Update. Greg McGurk, GMP Manager (acting) GMP Conference. 7 February 2017 Dublin

Quality Risk Management what s happening, the TGA and the how to

Process Design Risk Management A Proactive Approach

Setting the Scene CHALLENGES & COMPLEXITIES OF POST-APPROVAL CMC / LABELING CHANGES

Quality by Design Considerations for Analytical Procedures and Process Control

Revision of Chapter 7 Contract Manufacture and Analysis

Systematic Risk Management: An Overview of ICH Q-9

Application of ICH Q12 Tools and Enablers Post-Approval Lifecycle Management Protocols

Advantages, Opportunities & Challenges of Adopting the Post Approval Change Management Plan (PACMP)

THE NEW QUALITY PARADIGM OPPORTUNITIES AND EXPECTATIONS IN ICH Q8 Q9 Q10 Q11 DR. FRITZ ERNI

ICH Q10/WHO TRS A Regulatory Perspective

Application of ICH Q12 Tools and Enablers

Session 4: Quality Defect Investigations and Product Recalls

Cost-effective Purification of Vaccines, Data Integrity Systems and CTDs. DRAFT AGENDA Rio de Janeiro, 18 to 20 June 2018

Regulatory Update. Paul Sexton. QP Forum

Performance Based Regulatory Assessment

ICH Q11 Questions & Answers Selection & Justification of Starting Materials. Step 4 August Implementation Working Group

Changes without Prior Approval

PMDA Perspective: Regulatory Updates on Process Validation Standard

ICH guideline Q11 on development and manufacture of drug substances (chemical entities and biotechnological/biological entities)

Post Approval Changes & Product Lifecycle Management

PDA Comments ICH Q10; Pharmaceutical Quality System October Suggested Revision

Regulation of Active Pharmaceutical Ingredients (API)

Risk Based Validation. Why, How and with what tools?

Quality Risk Management

HR Excellence. Confederation of Indian Industry

Well Led Governance Review

TECHNICAL AND REGULATORY CONSIDERATIONS FOR PHARMACEUTICAL PRODUCT LIFECYCLE MANAGEMENT Q12

QbD In Drug Development. Mathew Cherian Ph.D. Director & Senior Fellow Pfizer, USA

Human Factors: CAA Action Plan

Consultation response: Dissolution testing in BP finished products monographs for solid oral dosage forms

PROPOSAL FOR REVISION OF THE SUPPLEMENTARY GUIDELINES ON GOOD MANUFACTURING PRACTICES: VALIDATION, APPENDIX 7:NON-STERILE PROCESS VALIDATION

ICH guideline Q12 on technical and regulatory considerations for pharmaceutical product lifecycle management

Stage 3 - Process Validation: Measuring what matters

Outsourcing - managing risks and opportunities over which you now have less control

Best Practices and Application of GMPs for Small Molecule Drugs in Early Development IQ Workshop, Feb 4-5, 2014, Washington, D.C.

Quality by Design: An Attempt to Jumpstart. Peter Calcott, Ph.D. President, Calcott Consulting

ICH Q9 An Industry Perspective: Ensuring Quality to Patients in a Risk-Based Regulatory Environment

Pharmaceutical quality requirements

Excipient Certification: Schemes and Auditable Standards - the role in Supplier Qualification

Introduction. Background and Context. Role and Function of the PSI. Developing the Corporate Strategy

The Future State Knowledge Management and Sharing to Reduce Regulatory Burden

INFORMATION GOVERNANCE COMPLIANCE IN WALES

Overview of the new pharmacovigilance legislation

MANUFACTURING CONTROL STRATEGY FOR CELL, GENE AND TISSUE PRODUCTS Christopher A Bravery

TECHNICAL AND REGULATORY CONSIDERATIONS FOR PHARMACEUTICAL PRODUCT LIFECYCLE MANAGEMENT Q12

Quality Risk Management

Management Board 16 June 2011 Budapest, Hungary

Strengthening Food Safety Systems in APEC Through Regulatory Cooperation

Process Validation Guidelines. Report highlights 23 rd February 2018

Clinical Relevance. Seeing the Big Picture

Re: PCIM/11/01 Public Consultation on Implementing Measures for Pharmacovigilance

ICH Q12 : A Unique Opportunity to Realize 21st Century Quality Vision

ACTIVITY WORK PLAN CONTENTS

Job Role Profile. Insert date/document version 1

Qualification and validation: - an inspector s perspective. Ian Rees, Unit Manager Inspectorate Strategy

PROPOSAL FOR REVISION OF THE SUPPLEMENTARY GUIDELINES ON GOOD MANUFACTURING PRACTICES: VALIDATION, APPENDIX 7:NON-STERILE PROCESS VALIDATION

Review article Rapports De Pharmacie 2015;1(2):46-53 ISSN:

Federal Institute for Drugs and Medical Devices ICH-Leitlinie Q 8 - Pharmaceutical Development die regulatorische Perspektive

Update from ECHA. REACH Information and Experience Exchange Forum (RIEF IV) CEFIC 19 June 2015 Sheraton Brussels Airport Hotel

NIRS, PAT, RTR testing EU experience and regulatory perspective

Work plan for the GMP/GDP Inspectors Working Group for 2017

We appreciate the opportunity to submit these comments for your consideration.

Application of Quality by Design in formulation and process Development

Pharmacovigilance System Master file

Update to the Manufacturing Principles for Medicinal Products

In the fall of 2004, the US Food

2nd FDA/PQRI Conference on Advancing Product Quality

EUROPEAN COMMISSION HEALTH AND CONSUMERS DIRECTORATE-GENERAL

EMA perspective on Quality Metrics

Update on SCOPE - Strengthening Collaborations to. Operate Pharmacovigilance in Europe

Impact of WHO Guidelines on GMP for Blood Establishments

Impacto de las Nuevas Tendencias Regulatorias en la Producción de Parenterales. Innovacion en Packaging Primario

Higher and Extended Project Qualifications ( /03)

CODEX COMMITTEE ON FOOD LABELLING (42nd Session) Rome, Italy, October 201

Update on the Regulatory Considerations of Pharmaceutical Product Lifecycle Management (ICH Q12) from a Health Authority Perspective

Internal Audit Quality Analysis Evaluation against the Standards International Standards for the Professional Practice of Internal Auditing (2017)

Strategies to Revise Quality Policy and Quality Objectives. Eileen Cortes February 22, 2017

Our Communications and Engagement Strategic Plan. (Supported by our Stakeholder Engagement Plan)

How to support regulatory capacity strengthening in Sub-Saharan Africa EMA Perspective

Identifying and Controlling CPPs and CMAs

Transcription:

Implementation of ICH Q8, Q9, Q10 Quality Risk Management International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use

Introduction Structure of this session - Goal & Key messages - 15 min - Discussion in sub groups - 80 min - Breakout report Clarity on key messages, Concerns, Need for clarification, Feedback - 25 min slide 3

Goals of this Breakout Facilitate understanding of the QRManagement process - Using example of the case study describe the QRM process - Ability to use the QRM process cycle in your organisation i.e. Development, Assessment, Manufacturing, Inspections / Audit Facilitate understanding of the linkage between QRM and knowledge management Feedback to Q-IWG slide 4

Key Message - Why use QRM? Use of QRM can improve the decision making processes from development, technical transfer, manufacturing, post approval changes and throughout the entire product life cycle slide 5

Key Messages Initiate Quality Risk Management Process Risk Assessment Quality Risk Management is the full process Quality Risk Assessment, Control, Review etc. represent only individual steps Risk Communication Risk Control Risk Review Risk Identification Risk Analysis Risk Evaluation Risk Reduction Risk Acceptance Output / Result of the Quality Risk Management Process unacceptable Risk Management tools Review Events ICH Q9 slide 6

Key Messages QRM is an iterative process and not a one off activity Utilisation of QRM activities should lead to a greater assurance of quality through risk control - Facilitate the awareness of risks - Risk does not go away - Risk can be predicted, prevented and controlled QRM processes should - Focus on what is important to establish the manufacturing process and controls and maintain them over the life cycle - Be integrated in Pharmaceutical Quality System elements slide 7

Key Messages QRM used by company can provide regulators with greater assurance of a company s product and process understanding and the ability to assure quality of manufactured products QRM should be used by regulators (both assessors and inspectors) to guide regulatory activities independent of the industry utilisation of QRM slide 8

Key Messages Regulators should use QRM methods appropriately to reach rational and justified regulatory decisions e.g. - Risk based regulatory decisions (suspected quality defects etc.) - Assessment of regulatory filing - Planning and conducting of inspections - Prioritisation of inspection findings slide 9

Research and clinical studies ICH Quality Implementation Working Group - Integrated Implementation Training Workshop QRM in the Product Life Cycle approx. life cycle time Patient needs Business needs Product design 1/4 3/4 Manufacturing Process design Knowledge management Technical Transfer Control Strategy Commercial Manufacturing PAI Inspections GMP Inspections Quality Target Product Profile (QTPP) Critical Quality Attribute (CQA) Critical Process Parameters (CPP) Technical regulatory Filing & Review Performance Review & Change Control Opportunities to apply Quality Risk Managements Process understanding slide 10

Key Messages Two primary principles of QRM are The evaluation of the risk to quality should be based on scientific knowledge and ultimately link to the protection of the patient The level of effort, formality and documentation of the quality risk management process should be commensurate with the level of risk ICH Q9 slide 11

Key Messages Reduce subjectivity of implementing QRM by making sure the right people are at the table (e.g. multi-discipline, include respective stakeholders, as applicable) Use QRM methods appropriately and present the conclusions and justifications clearly - Be clear and consistent in wording / terms used based on internationally agreed definitions - Transparency on the logic of the methodology and the decision making - QRM can not be used to justify failure Use QRM proactively for increasing the knowledge of your product and processes slide 12

Linkage between QRM and Knowledge Management Definition on Knowledge Management Systematic approach to acquiring, analysing, storing, and disseminating information related to products, manufacturing processes and components (ICH Q10) slide 13

Linkage between QRM and Knowledge Management Risk Communication Initiate Quality Risk Management Process Risk Assessment Risk Identification Risk Analysis Risk Evaluation Risk Control Risk Reduction Risk Acceptance Output / Result of the Quality Risk Management Process Risk Review Review Events unacceptable Risk Management tools Risk assessment as part of QRM in relation to knowledge management can be linked to - Identifying data to be collected (risk identification) - Analysing raw data (risk analysis) - Evaluating the results from measurement will lead to information (risk evaluation) New information should be assessed and the risk control decision captured (risk review and risk control) Knowledge management facilitates risk communication among stakeholders slide 14

Linkage between QRM and Knowledge Management In conjunction with QRM, Knowledge Management as systematic activity can facilitate e.g. - Usage of prior knowledge (including from other similar products) - Development, implementation and maintenance of the Design Space and Control Strategy - Technology transfer - Continual improvement of the product and manufacturing processes across its life cycle - Continual improvement of Quality System elements (including documentation) slide 15

Breakout in sub-teams Assessors Inspectors Manufacturing Development Others slide 16

Topics to discuss in the sub teams Introduce yourself and tell your expectation for this QRM breakout slide 17

Which QRM step this example belongs to? slide 18

Which QRM step this example belongs to? slide 19

Which QRM step this example belongs to? slide 20

Which QRM step this example belongs to? slide 21

Which QRM step this example belongs to? slide 22

Which QRM step this example belongs to? slide 23

Topics to Discuss 1. What is the benefit using QRM in development, assessment, manufacturing and/or inspection? 2. What is the expectations of the level of training and understanding for regulators and industry in order to use the methods appropriately? 3. How to link quality risk management to knowledge management? 4. What level of detail on QRM need to be included in a submission (general / case by case)? slide 24

Topics to Discuss A. How can industry demonstrate the robustness of a QRM process? Aa) In regulatory filing? Ab) In manufacturing operations? B. How does an assessor independently evaluate the companies risk management conclusion? C. How could inspectors use QRM principles to align risk based decisions? slide 25

Feedback to ICH Q-IWG Are we clear with the key messages? Yes / No Are there practical concerns on implementation? (e.g. on harmonisation among regions needed, by region/local issue) Where is more clarification required for practical harmonised implementation? slide 26

Did we meet the goals? Facilitate understanding of the QRManagement process - Using example of the case study describe the QRM process - Ability to use the QRM process cycle in your organisation i.e. Development, Assessment, Manufacturing, Inspections/Audit Facilitate understanding of the linkage between QRM and knowledge management Feedback to Q-IWG slide 27